Massimiliano Secchi

Via Abbiategrasso 207
Pavia, 27100, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential Inhibitors.

Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential Inhibitors.

Journal: International journal of molecular sciences
Published: November 11, 2025

Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loops.

Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loops.

Journal: Nucleic acids research
Published: November 28, 2023

Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNA.

Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNA.

Journal: International journal of molecular sciences
Published: December 30, 2022

Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity.

Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity.

Journal: Molecules (Basel, Switzerland)
Published: October 31, 2022

Editorial: CCR5: A receptor at the center stage in infection.

Editorial: CCR5: A receptor at the center stage in infection.

Journal: Frontiers in immunology
Published: September 26, 2022

Rational Engineering of a Sub-Picomolar HIV-1 Blocker.

Rational Engineering of a Sub-Picomolar HIV-1 Blocker.

Journal: Viruses
Published: September 09, 2022

DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective.

DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective.

Journal: Cancers
Published: July 12, 2022

Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2.

Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2.

Journal: Frontiers in immunology
Published: June 13, 2022

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.

Journal: Nature communications
Published: January 27, 2021

Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia.

Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia.

Journal: The Journal of clinical endocrinology and metabolism
Published: December 21, 2020

Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis.

Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis.

Journal: Clinical and translational gastroenterology
Published: October 08, 2020

A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children.

A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children.

Journal: Med (New York, N.Y.)
Published: September 02, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026